Departamento de Biología, Facultad de Química, Universidad Nacional Autónoma de México, Mexico, DF, Mexico.
Mol Cell Biochem. 2012 Oct;369(1-2):105-17. doi: 10.1007/s11010-012-1373-0. Epub 2012 Jul 4.
Renal cell carcinoma (RCC), the commonest malignancy in adult kidney, lacks of early signs, resulting often in metastasis at first diagnosis. N-Diethylnitrosamine (DEN)-initiated and ferric nitrilotriacetate (FeNTA)-promoted RCC may be a useful experimental model, but it is not well characterized. In this study, histological alterations and oxidative stress markers were analyzed at different times throughout RCC development, histological subtype was re-evaluated in the light of current classification, and a tamarind seed extract (TSE) effect was examined. Male Wistar rats experimental groups were control, TSE, DEN, DEN+FeNTA, and TSE+DEN+FeNTA. TSE was given 2 weeks before DEN administration (200 mg/kg) and throughout the experiment. Fourteen days after DEN treatment, two FeNTA doses (9 mg Fe/kg) for acute nephrotoxicity study, and increasing FeNTA doses (3-9 mg Fe/kg) twice a week for 16 weeks for carcinogenesis protocol, were administered. In acute study, necrosis and renal failure were observed and TSE ameliorated them. Throughout carcinogenesis protocol, preneoplastic lesions were observed since 1 month of FeNTA treatment, which were more evident at 2 months, when also renal cysts and RCC were already detected. RCC tumors were obtained without changes in renal function, and clear cell histological subtype was identified in all cases. 4-Hydroxy-2-nonenal and 3-nitro-L: -tyrosine levels increased progressively throughout protocol. TSE decreased both oxidative stress markers and, although there was no statistical difference, it delayed RCC progress and decreased its incidence (21 %). This study brings an insight of the time course events in this carcinogenesis model, identifies clear cell subtype and establishes TSE renoprotective effects.
肾细胞癌(RCC)是成人肾脏中最常见的恶性肿瘤,缺乏早期迹象,因此通常在首次诊断时就已经发生转移。N-二乙基亚硝胺(DEN)诱导和三乙四胺五乙酸铁(FeNTA)促进的 RCC 可能是一种有用的实验模型,但尚未得到很好的描述。在这项研究中,我们在整个 RCC 发展过程中的不同时间分析了组织学改变和氧化应激标志物,根据当前的分类重新评估了组织学亚型,并研究了罗望子种子提取物(TSE)的作用。雄性 Wistar 大鼠实验组包括对照组、TSE 组、DEN 组、DEN+FeNTA 组和 TSE+DEN+FeNTA 组。TSE 在 DEN 给药前 2 周(200mg/kg)和整个实验期间给予。DEN 处理后 14 天,进行了两次 FeNTA 剂量(9mgFe/kg)的急性肾毒性研究,以及每周两次给予递增的 FeNTA 剂量(3-9mgFe/kg)进行 16 周的致癌作用研究。在急性研究中,观察到坏死和肾衰竭,TSE 改善了这些病变。在致癌作用研究过程中,从 FeNTA 处理 1 个月开始就观察到了癌前病变,在 2 个月时更为明显,此时已经检测到了肾囊肿和 RCC。在肾功能没有变化的情况下获得了 RCC 肿瘤,并且在所有病例中都鉴定出了透明细胞组织学亚型。4-羟基-2-壬烯醛和 3-硝基-L:-酪氨酸水平在整个研究过程中逐渐升高。TSE 降低了两种氧化应激标志物,尽管没有统计学差异,但它延迟了 RCC 的进展并降低了其发生率(21%)。本研究深入了解了该致癌模型的时间进程事件,鉴定了透明细胞亚型,并确定了 TSE 的肾保护作用。